DK434884A - Benzothiopen-derivater til anvendelse som midler mod astma samt farmaceutiske formuleringer indeholdende saadanne derivater - Google Patents

Benzothiopen-derivater til anvendelse som midler mod astma samt farmaceutiske formuleringer indeholdende saadanne derivater Download PDF

Info

Publication number
DK434884A
DK434884A DK434884A DK434884A DK434884A DK 434884 A DK434884 A DK 434884A DK 434884 A DK434884 A DK 434884A DK 434884 A DK434884 A DK 434884A DK 434884 A DK434884 A DK 434884A
Authority
DK
Denmark
Prior art keywords
derivatives
benzothiopen
astma
pharmaceutical formulations
formulations containing
Prior art date
Application number
DK434884A
Other languages
English (en)
Other versions
DK158972B (da
DK434884D0 (da
DK158972C (da
Inventor
Peter Peck Koh Ho
Quentin Francis Soper
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK434884D0 publication Critical patent/DK434884D0/da
Publication of DK434884A publication Critical patent/DK434884A/da
Publication of DK158972B publication Critical patent/DK158972B/da
Application granted granted Critical
Publication of DK158972C publication Critical patent/DK158972C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Seal Device For Vehicle (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK434884A 1983-09-13 1984-09-12 Farmaceutiske formuleringer indeholdende benzothiophenderivater DK158972C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53180283 1983-09-13
US06/531,802 US4552891A (en) 1983-09-13 1983-09-13 Benzothiophene derivatives

Publications (4)

Publication Number Publication Date
DK434884D0 DK434884D0 (da) 1984-09-12
DK434884A true DK434884A (da) 1985-03-14
DK158972B DK158972B (da) 1990-08-13
DK158972C DK158972C (da) 1991-01-07

Family

ID=24119104

Family Applications (1)

Application Number Title Priority Date Filing Date
DK434884A DK158972C (da) 1983-09-13 1984-09-12 Farmaceutiske formuleringer indeholdende benzothiophenderivater

Country Status (18)

Country Link
US (1) US4552891A (da)
EP (1) EP0139464B1 (da)
JP (1) JPS6084221A (da)
AT (1) ATE38036T1 (da)
AU (1) AU563650B2 (da)
CA (1) CA1229047A (da)
CY (1) CY1513A (da)
DE (2) DE3433475A1 (da)
DK (1) DK158972C (da)
GB (1) GB2146527B (da)
HK (1) HK38990A (da)
IL (1) IL72928A (da)
IT (1) IT1176702B (da)
MY (1) MY101614A (da)
NZ (1) NZ209516A (da)
PH (1) PH21102A (da)
SG (1) SG74789G (da)
ZA (1) ZA847193B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0253650A3 (en) * 1986-07-18 1989-09-13 Eli Lilly And Company Improvements relating to benzothiophene derivatives
GB8816519D0 (en) * 1987-07-23 1988-08-17 Ici Plc Antibiotic compounds
US4863923A (en) * 1988-07-01 1989-09-05 Eli Lilly And Company Method of inhibiting superoxide release
CZ181493A3 (en) * 1992-09-10 1994-03-16 Lilly Co Eli The use of rhodanine derivative for the preparation of a pharmaceutical composition reducing level of sugar in blood and for treating alzheimer's disease
US6251928B1 (en) * 1994-03-16 2001-06-26 Eli Lilly And Company Treatment of alzheimer's disease employing inhibitors of cathepsin D
US6426084B1 (en) 2000-06-19 2002-07-30 Neal R. Cutler Treatment of sexual dysfunction in certain patient groups
US6187790B1 (en) 1999-03-04 2001-02-13 Neal R. Cutler Use of cilostazol for treatment of sexual dysfunction
US6132757A (en) 1998-05-01 2000-10-17 Neal R. Cutler Treatment of sexual dysfunction in certain patient groups
PL200923B1 (pl) 1999-08-21 2009-02-27 Nycomed Gmbh Lek zawierający inhibitor PDE w połączeniu z agonistą receptoraß₂ -adrenergicznego oraz zastosowanie połączenia roflumilastu i salmeterolu
US6451813B1 (en) 2001-01-26 2002-09-17 R. T. Alamo Ventures I, Llc Treatment of gastroparesis in certain patient groups
US6562838B2 (en) * 2001-01-26 2003-05-13 R. T. Alamo Ventures I, L.L.C. Treatment of cardiovascular disease with quinolinone enantiomers
US6458804B1 (en) * 2001-01-26 2002-10-01 R.T. Alamo Venturesi, Llc Methods for the treatment of central nervous system disorders in certain patient groups
US20030096748A1 (en) * 2001-06-04 2003-05-22 The Regents Of The University Of Michigan Methods and compositions for the treatment of diseases associated with signal transduction aberrations
US7041677B2 (en) * 2002-03-01 2006-05-09 R.T. Alamo Ventures I, Llc Use of monochloroflosequinan in the treatment of sexual dysfunction
US7208628B2 (en) * 2002-05-13 2007-04-24 Kansas State University Research Foundation Compositions and methods for the treatment of hepatitis C virus infection
US7074893B2 (en) * 2002-06-03 2006-07-11 Regents Of The University Of Michigan Methods and compositions for the treatment of diseases associated with signal transduction aberrations
JP2006522151A (ja) 2003-04-01 2006-09-28 アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ 不妊症におけるホスホジエステラーゼ阻害剤
US20050089558A1 (en) * 2003-10-28 2005-04-28 Alamo Pharmaceuticals, Llc Compositions and methods for the co-formulation and administration of tramadol and propoxyphene
US7872027B2 (en) * 2006-02-17 2011-01-18 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Low molecular weight Myc-max inhibitors
JP6897971B2 (ja) 2015-05-15 2021-07-07 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 関節炎を処置するための、方法および組成物
WO2019094469A1 (en) 2017-11-07 2019-05-16 The Regents Of The University Of Michigan Small molecule inhibitors of shared epitope-calreticulin interactions and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH508615A (de) * 1968-05-30 1971-06-15 Ciba Geigy Ag Verfahren zur Herstellung von neuen heterocyclischen Carbonsäuren
US4101668A (en) * 1977-05-10 1978-07-18 Bristol-Myers Company Antiosteoporotic agents

Also Published As

Publication number Publication date
AU3192084A (en) 1985-03-21
IT1176702B (it) 1987-08-18
DE3433475A1 (de) 1985-03-28
IL72928A (en) 1987-10-20
CY1513A (en) 1990-08-03
IT8422626A1 (it) 1986-03-12
DK158972B (da) 1990-08-13
PH21102A (en) 1987-07-16
SG74789G (en) 1990-04-20
JPS6084221A (ja) 1985-05-13
DE3433475C2 (da) 1992-12-24
EP0139464A1 (en) 1985-05-02
HK38990A (en) 1990-05-25
DK434884D0 (da) 1984-09-12
ZA847193B (en) 1986-04-30
EP0139464B1 (en) 1988-10-19
DE3474662D1 (en) 1988-11-24
GB2146527A (en) 1985-04-24
US4552891A (en) 1985-11-12
AU563650B2 (en) 1987-07-16
IL72928A0 (en) 1984-12-31
GB8423081D0 (en) 1984-10-17
MY101614A (en) 1991-12-17
IT8422626A0 (it) 1984-09-12
CA1229047A (en) 1987-11-10
ATE38036T1 (de) 1988-11-15
NZ209516A (en) 1987-01-23
DK158972C (da) 1991-01-07
GB2146527B (en) 1987-05-20

Similar Documents

Publication Publication Date Title
DK434884D0 (da) Benzothiopen-derivater til anvendelse som midler mod astma samt farmaceutiske formuleringer indeholdende saadanne derivater
DK160052C (da) Chlorsubstituerede disaccharider og fremgangsmaader til fremstilling deraf samt praeparater indeholdende sacchariderne som soedemidler
GR3006630T3 (da)
ES517828A0 (es) Dispositivo para la esterilizacion de al menos un biberon o de al menos una tetina.
ES503053A0 (es) Aparato para el tratamiento de fluidos,particularmente san- gre
MX9704037A (es) 1,1-dioxidos de 1,2,5-tiadiazolidin-3-ona 2-substituida y composiciones y metodo de uso de los mismos.
DK160981C (da) Arylsulfonylurinstof-derivater, fremgangsmaade til fremstilling deraf, anvendelse af disse som terapeutisk og antineoplastisk middel samt farmaceutiske midler indeholdende saadanne derivater
IT8447911A1 (it) Apparecchiatura per il trattamento di bottiglia e simili.
NO885670L (no) Fortilsetning og for som inneholder denne tilsetning.
DK0471756T3 (da) Saccharinderivater, der er egnede som proteolytiske enzyminhibitorer, og fremstilling deraf
NO921382D0 (no) Amidinofenylalaninderivater, samt fremstilling, anvendelse og preparater inneholdende forbindelsene
IT8467840A1 (it) Composto e composizione farmaceutica per il trattamento della osteoporosi.
DK388484D0 (da) Chromonalkaloid, fremgangsmaade til isolering deraf fra dysoxylum binectariferum samt dets anvendelse som laegemiddel
DK378988A (da) Dopamin-beta-hydroxylaseinhibitorer, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende disse forbindelser
DK243989A (da) Ringsubstituerede 2-amino-1,2,3,4-tetrahydronaphthalener, fremgangsmaade til fremstilling af saadanne forbindelser og laegemidler indeholdende disse
NO307364B1 (no) Anvendelse av melatoninderivater
NO860733L (no) N-(2-klor-4-trifluormethylfenyl)-3-trifluormethyl-benzensulfonamidderivat, fremgangsmaate for fremstilling av dette, og fungicid middel inneholdende dette.
DK585984D0 (da) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan og salte deraf til anvendelse ved bekaempelse af sygdomme samt fremgangsmaade til fremstilling af saadanne nonanderivater
DK7783A (da) Fremgangsmaade til fremstilling af beta-lactamase-inhibitorer og kompositioner indeholdende saadanne, samt mellemprodukter for inhibitorerne
MX9704035A (es) 1,1-dioxidos de 2-(fosfiniloximetil)-1,2,5-tiadiazolidin-3-ona substituidos y composiciones y metodo de uso de los mismos.
DK260884A (da) 7-oxo-4-thia-1-azabicyclo(3.2.0)hept-2-en-derivater, fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
GB2142024B (en) Terphenyl derivatives
MX9704036A (es) 1,1-dioxidos y composiciones de 2-(2,3,5,6-tetrafluoro-4-piridil)-1,2,5-thiadizaolidin-3-ona y metodo de uso.
IT8719135A0 (it) Procedimento ed attrezzo per lasigillatura di bare o feretri ebara relativa.
NO884011L (no) Fremgangsmaate for stabilisering av blandinger som inneholder klorfluoralkaner.

Legal Events

Date Code Title Description
PBP Patent lapsed